Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for CBT-assessment of Paranoid Delusions in Schizophrenia
NCT00742079Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2006
- Primary completion
- Jul 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of d-cycloserine in schizophrenia, sponsored by Massachusetts General Hospital. Started Sep 2006; status: completed.
02
Drugs
d-cycloserine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00742079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742079.